Interethnic studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondylitis

Genes and Immunity

Volumn 1, Issue 7, 2000, Pages 418-422

  Milicic, A ^a   Lindheimer, F ^b   Laval, S ^c   Rudwaleit, M ^d   Ackerman, H ^c   Wordsworth, P ^a   Hohler, T ^b   Brown, M A ^a,c  

^a NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Ankylosing spondylitis; Association; TNF

Indexed keywords

PRIMER DNA; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CASE CONTROL STUDY; ETHNIC GROUP; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; GERMANY; HUMAN; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEOTIDE SEQUENCE; PROMOTER REGION; UNITED KINGDOM;

ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; ENGLAND; ETHNIC GROUPS; GENE FREQUENCY; GENOTYPE; GERMANY; HUMANS; LINKAGE DISEQUILIBRIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034303168     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363701     Document Type: Article

References (37)

1. Brown MA, Kennedy LG, MacGregor AJ et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997; 40: 1823-1828.
2. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet 1973; 1: 904-907.
3. Brown MA, Pile KD, Kennedy LG et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996; 55: 268-270.
4. van der Linden SM, Valkenburg HA, de Jongh BM, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984; 27: 241-249.
5. Braun J, Bollow M, Remlinger G et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998; 41: 58-67.
6. Brown MA, Pile KD, Kennedy LG et al. A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum 1998; 41: 588-595.
7. Brown MA, Wordsworth BP. Predisposing factors to spondyloarthropathies. Curr Opin Rheumatol 1997; 9: 308-314.
8. Brown MA, Pile KD, Klinke J et al. HLA Class II associations of ankylosing spondylitis. Br J Rheumatol 1995; 34 (Abstracts Supplement 1): 146.
9. Nahal R, Gautreau C, Amor B et al. Genetic investigation in familial spondyloarthropathy (SpA) with focus on HLA region using transmission desequilibrium test (TDT). Arthritis Rheum 1996; 39: S122.
10. Laval SH, Bradbury L, Darke C, Brophy S, Calin A, Brown M. The role of HLA-DR genes in ankylosing spondylitis complicating inflammatory bowel disease. Rheumatology 2000; 39 (Suppl. 1): 64.
11. Braun J, Bollow M, Neure L et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondy-litis. Arthritis Rheum 1995; 38: 499-505.
12. McGarry F, Walker R, Sturrock R, Field M. The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27. J Rheumatol 1999; 26: 1110-1116.
13. Hohler T, Schaper T, Schneider PM, Meyer zum Buschenfelde KH, Marker-Hermann E. Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum 1998; 41: 1489-1492.
14. Whichelow CE, Hitman GA, Raafat I, Bottazzo GF, Sachs JA. The effect of TNF*B gene polymorphism on TNF-alpha and -beta secretion levels in patients with insulin-dependent diabetes mellitus and healthy controls. Eur J Immunogenet 1996; 23: 425-435.
15. Bouma G, Crusius JB, Oudkerk Pool M et al. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immitnol 1996; 43: 456-463.
16. Galbraith GM, Steed RB, Sanders JJ, Pandey JP. Tumor necrosis factor alpha production by oral leukocytes: influence of tumor necrosis factor genotype. J Periodontol 1998; 69: 428-433.
17. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997; 34: 391-399.
18. Louis E, Franchimont D, Piron A et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401-406.
19. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
20. Stuber F, Udalova IA, Book M et al. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1995; 46: 42-50.
21. Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation. J Inflamm 1995; 46: 32-41.
22. Pociot F, D'Alfonso S, Compasso S, Scorza R, Richiardi PM. Functional analysis of a new polymorphism in the human TNF alpha gene promoter. Scand J Immunol 1995; 42: 501-504.
23. Kaijzel EL, Brinkman BM, van Krugten MV et al. Polymorphism within the tumor necrosis factor alpha (TNF) promoter region in patients with ankylosing spondylitis. Hum Immunol 1999; 60: 140-144.
24. Knight JC, Udalova I, Hill AV et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999; 22: 145-150.
25. Fraile A, Nieto A, Beraun Y, Vinasco J, Mataran L, Martin J. Tumor necrosis factor gene polymorphisms in ankylosing spondylitis. Tissue Antigens 1998; 51: 386-390.
26. Verjans GM, Brinkman BM, Van-Doornik CE, Kijlstra A, Venveij CL. Polymorphism of tumour necrosis factor-alpha (TNF-alpha) at position -308 in relation to ankylosing spondylitis. Clin Exp Immunol 1994; 97: 45-47.
27. Rudwaleit M, Tikly M, Khamashta M et al. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 1996; 23: 1725-1728.
28. Cohen J. 1988 Statistical Power Analysis for the Behavioural Sciences, 2nd edn. Lawrence Erlbaum Associates, Hillsdale, New Jersey, 1988.
29. Brown MA, Kennedy LG, Darke C et al. The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. Arthritis Rheum 1998; 41: 460-465.
30. Roussomoustakaki M, Satsangi J, Welsh K et al. Genetic markers may predict disease behaviour in patients with ulcerative colitis. Gastroenterology 1997; 112: 1845-1853.
31. Skoog T, van't Hooft FM, Kallin B et al. A common functional polymorphism (C→A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999; 8: 1443-1449.
32. Rood MJ, van Krugten MV, Zanelli E et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000; 43: 129-134.
33. Bali D, Gourley S, Kostyu D et al. Genetic analysis of multiplex rheumatoid arthritis families. Genes Immun 1999; 1: 28-36.
34. Mulcahy B, Waldron Lynch F, McDermott MF et al. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet 1996; 59: 676-683.
35. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-368.
36. Lathrop GM. Estimating genotype relative risks. Tissue Antigens 1983; 22: 160-166.
37. Lewontin R. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964; 49: 49-67.